Literature DB >> 6345548

A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera.

M E Melville-Smith, V A Seagroatt, J T Watkins.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) has been developed for the measurement of tetanus antitoxin in human sera as an alternative to the toxin neutralization test in mice, the currently accepted method of assay. The ELISA was found to be simple and quick to perform and required only small amounts of materials. In addition, the assay was found to give reproducible estimates of antitoxin levels and to measure antitoxin at levels as low as 0.01 IU per ml, a sensitivity similar to that of the neutralization test. Furthermore, a comparison of the results of the ELISA and the neutralization test involving 80 human sera, including sera with both high and low antitoxin levels, showed close agreement in antitoxin levels obtained by the two methods. It was concluded that ELISA was an acceptable alternative to the toxin neutralization test in mice for the measurement of tetanus antitoxin levels in human sera.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345548     DOI: 10.1016/s0092-1157(83)80038-9

Source DB:  PubMed          Journal:  J Biol Stand        ISSN: 0092-1157


  32 in total

1.  Time resolved fluorometric immunoassay, using europium labelled antihuman IgG, for the detection of human tetanus antitoxin in serum.

Authors:  P A Maple; C S Jones; N J Andrews
Journal:  J Clin Pathol       Date:  2001-10       Impact factor: 3.411

2.  Comparison of five commercial anti-tetanus toxoid immunoglobulin G enzyme-linked immunosorbent assays.

Authors:  A L Perry; A J Hayes; H A Cox; F Alcock; A R Parker
Journal:  Clin Vaccine Immunol       Date:  2009-09-30

3.  Routine immunisation of preterm infants.

Authors:  C R Pullan; D Hull
Journal:  Arch Dis Child       Date:  1989-10       Impact factor: 3.791

4.  Immunogenicity and reactogenicity of a combined DTPw-hepatitis B vaccine in Lithuanian infants.

Authors:  V Usonis; V Bakasenas; D Taylor; P Vandepapeliere
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

5.  Evaluation of test immunisation in the assessment of antibody deficiency syndromes.

Authors:  A D Webster; A A Latif; M K Brenner; D Bird
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-23

6.  Detection of tetanus toxoid antibodies in human sera in New Zealand by ELISA.

Authors:  R C Lau
Journal:  Epidemiol Infect       Date:  1987-04       Impact factor: 2.451

7.  Detection of tetanus antitoxin using Eu(3+)-labeled anti-human immunoglobulin G monoclonal antibodies in a time-resolved fluorescence immunoassay.

Authors:  J P Schröder; W D Kuhlmann
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

8.  Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children.

Authors:  G Kanra; M Ceyhan; D Vandevoorde; H Bogaerts
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

9.  Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.

Authors:  K Redhead; J Watkins; A Barnard; K H Mills
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom.

Authors:  Jo Southern; Ray Borrow; Nick Andrews; Rhonwen Morris; Pauline Waight; Michael Hudson; Paul Balmer; Helen Findlow; Jamie Findlow; Elizabeth Miller
Journal:  Clin Vaccine Immunol       Date:  2008-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.